Literature DB >> 3005651

Mapping 5' termini of JC virus late RNA.

S Kenney, V Natarajan, N P Salzman.   

Abstract

The 5' termini of late mRNAs were mapped 17 to 19 days after primary human fetal glial cells were infected with JC virus. The major 5' start sites spanned a region of approximately 250 nucleotides, starting at nucleotide 5114, which was on the early side of the replication origin, and extending to nucleotide 242, which was on the late side of the 98-base-pair (bp) repeats. The sequence TATATAT was contained within each of the 98-bp repeats but does not specify 5' start sites in vivo. However, the sequence TACCTA, which occurred 25 to 30 bp upstream of the simian virus 40 nucleotide position 325 start site (J. Brady, M. Radonovich, M. Vodkin, V. Natarajan, M. Thoren, G. Das, J. Janik, and N. P. Salzman, Cell 31:625-633, 1982) and functions as a surrogate TATA box, was present 30 bp upstream of two JC virus start sites.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005651      PMCID: PMC252896     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  The 5'-terminal leader sequence of late 16 S mRNA from cells infected with simian virus 40.

Authors:  P K Ghosh; V B Reddy; J Swinscoe; P V Choudary; P Lebowitz; S M Weissman
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

2.  Localization of the 5' terminus of late SV40 mRNA.

Authors:  G Haegeman; W Fiers
Journal:  Nucleic Acids Res       Date:  1978-07       Impact factor: 16.971

3.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

4.  JC Papovavirus in progressive multifocal leukoencephalopathy.

Authors:  B L Padgett; D L Walker; G M ZuRhein; A E Hodach; S M Chou
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

5.  Mapping the spliced and unspliced late lytic SV40 RNAs.

Authors:  C J Lai; R Dhar; G Khoury
Journal:  Cell       Date:  1978-08       Impact factor: 41.582

6.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

7.  Transcription maps of adenovirus.

Authors:  P A Sharp; A J Berk; S M Berget
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract.

Authors:  J L Manley; A Fire; A Cano; P A Sharp; M L Gefter
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

9.  Site-specific base substitution and deletion mutations that enhance or suppress transcription of the SV40 major late RNA.

Authors:  J Brady; M Radonovich; M Vodkin; V Natarajan; M Thoren; G Das; J Janik; N P Salzman
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

10.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

View more
  18 in total

1.  Unusual DNA structure in the regulatory region of the human papovavirus JC virus.

Authors:  S Amirhaeri; F Wohlrab; E O Major; R D Wells
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent.

Authors:  S Kenney; J Kamine; E Holley-Guthrie; E C Mar; J C Lin; D Markovitz; J Pagano
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

3.  The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.

Authors:  S Kenney; J Kamine; E Holley-Guthrie; J C Lin; E C Mar; J Pagano
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

4.  Analysis of capsid formation of human polyomavirus JC (Tokyo-1 strain) by a eukaryotic expression system: splicing of late RNAs, translation and nuclear transport of major capsid protein VP1, and capsid assembly.

Authors:  Y Shishido-Hara; Y Hara; T Larson; K Yasui; K Nagashima; G L Stoner
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Mapping 5' termini of JC virus early RNAs.

Authors:  S Kenney; V Natarajan; G Selzer; N P Salzman
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

6.  Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells.

Authors:  H Tada; J Rappaport; M Lashgari; S Amini; F Wong-Staal; K Khalili
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

Review 7.  Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.

Authors:  Leslie J Marshall; Eugene O Major
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-17       Impact factor: 4.147

8.  A novel sequence-specific DNA-binding protein, LCP-1, interacts with single-stranded DNA and differentially regulates early gene expression of the human neurotropic JC virus.

Authors:  H Tada; K Khalili
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.

Authors:  M Chowdhury; J P Taylor; C F Chang; J Rappaport; K Khalili
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  The transcriptional enhancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS.

Authors:  P N Ranganathan; K Khalili
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.